Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Avista Pharma Spends $4mn to Upgrade Capabilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

Avista Pharma Spends $4mn to Upgrade Capabilities

Expands microbiology, sterility testing and microbial ID capabilities at Agawam facility

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Avista Pharma Solutions has completed the $4 million expansion of its 26,000-square foot contract testing facility in Agawam, MA. The improved facility has 4,200 square feet of additional space, featuring a new microbiology laboratory as well as a modular cleanroom area, which houses isolator technology and an ISO 6 cleanroom used for sterility testing of medical devices, pharmaceuticals, and biologics. In addition, the laboratory support division has implemented new pass-through autoclaves and labware processing technologies that streamline workflow and complement Avista Pharma’s extensive suite of microbiology services.

The facility’s full range of comprehensive services will continue to include raw material and finished product release testing, ICH stability and storage, container closure integrity testing (CCIT), water system testing and validation, cleanroom monitoring and risk assessments, microbial identification via both MicroSEQ ID (rapid 16S rDNA sequencing) and Vitek MS (MALDI-TOF), mycoplasma testing, antimicrobial effectiveness testing (AET), microbial enumeration testing (MET), endotoxin and bioburden testing and disinfectant efficacy qualifications.

“We remain committed to providing best-in-class microbiology, analytical chemistry and cleanroom services,” said Patrick Walsh, chief executive officer, Avista Pharma. “This investment will complement our existing capabilities and expand our service offerings for our pharmaceutical and medical device clients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters